[Effects of VIMANG on various markers of HIV-1 progression in Cuban patients].
68 patients divided into 2 groups were studied, one that received VIMANG during 6 months and another that was administered placebo. Titers of anti-p24 antibodies and concentration of antigen p24 were measured at 0 and 6 months. The differences found in the behavior of the titers of the antibodies between both groups were not significant, although the TPG were maintained in the group receiving VIMANG. In the placebo group, 2 patients elevated the antigen concentration and 2 were positive for this marker, whereas in the study group the Ag disappeared in a patient who became positive but with values 3 and 4 times lower than in the 2 patients of the control group, where it increased.
Santos
Lissette Pérez
LP
Instituto de Medicina Tropical "Pedro Kourí", Ciudad de La Habana, Cuba. ciipk@ipk.sld.cu
Aguirre
Sonia Resik
SR
Fernández
Reynel Cancio
RC
Robaina
Maité
M
del Valle
Lizette Gil
LG
D015415:Biomarkers / Q000097:blood; D018450:Disease Progression; D004311:Double-Blind Method; D015658:HIV Infections / Q000097:blood* / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D031022:Mangifera; D008517:Phytotherapy; D010936:Plant Extracts / Q000627:therapeutic use*; D013997:Time Factors
D015415:Biomarkers; D010936:Plant Extracts